PGEN
Precigen Inc
Precigen Inc historical holders
total: 5
Miller Value Partners Precigen Inc transactions over time
- Total transactions:
- 36
- New positions:
- 2
- Sold out:
- 2
- Added:
- 21
- Reduced:
- 11
- Held since:
- 2023 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2023 Q2
Bill Miller has been an institutional investor in Precigen Inc (PGEN) since 2013 Q4. According to 2026 Q1 report, Bill Miller doesn't hold any shares. The fund/company first acquired PGEN in 2013 Q4, initially purchasing about 1.17M shares. Bill Miller later completely sold out the position and reinvested in PGEN again in 2023 Q1. Since the initial investment, Miller Value Partners has made 35 more transactions in this position.
When did Bill Miller exit their PGEN position?
Bill Miller no longer holds Precigen Inc (PGEN). They sold off their entire position in 2023 Q2, closing out an investment that began in 2013 Q4.
When did Bill Miller first invest in PGEN?
Bill Miller first invested in Precigen Inc (PGEN) in 2013 Q4 at the reported quarter-end price of $23.80 per share, acquiring 1,173,000 shares in their initial purchase.
What is Bill Miller's average cost basis for PGEN?
Based on historical transaction data, Bill Miller's estimated cost basis for Precigen Inc (PGEN) is approximately $1.06 per share. This represents their average reported price* across all buy transactions.
Has Bill Miller reinvested in PGEN after selling?
Yes, Bill Miller has shown renewed interest in Precigen Inc (PGEN). After completely selling their position, they reinitiated an investment in 2023 Q1, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $1.06
- Weighted AVG sell price:
- $1.06
PGEN transactions history by Miller Value Partners
36 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q2
|
0.00%
|
0
|
$1.06
|
|
-100% (-9,503,782)
|
-0.63%
|
|
2023 Q1
|
0.63%
|
9,503,782
|
$1.06
|
$10,074,009
|
new
|
+0.63%
|
|
2022 Q3
|
0.00%
|
0
|
$1.34
|
|
-100% (-5,598,807)
|
-0.42%
|
|
2022 Q2
|
0.42%
|
5,598,807
|
$1.34
|
$7,503,000
|
-12.40% (-792,548)
|
-0.04%
|
|
2022 Q1
|
0.51%
|
6,391,355
|
$2.11
|
$13,485,000
|
-0.66% (-42,583)
|
-0%
|
|
2021 Q4
|
0.84%
|
6,433,938
|
$3.71
|
$23,870,000
|
-20.17% (-1,625,183)
|
-0.21%
|
|
2021 Q3
|
1.37%
|
8,059,121
|
$4.99
|
$40,215,000
|
-12.95% (-1,198,747)
|
-0.16%
|
|
2021 Q2
|
1.57%
|
9,257,868
|
$6.52
|
$60,362,000
|
+1.72% (+156,393)
|
+0.03%
|
|
2021 Q1
|
1.78%
|
9,101,475
|
$6.89
|
$62,709,000
|
+27.58% (+1,967,381)
|
+0.38%
|
|
2020 Q4
|
2.46%
|
$10.20
|
-5.62% (-424,482)
|
|||
|
2020 Q3
|
1.05%
|
$3.50
|
-2.14% (-165,659)
|
|||
|
2020 Q2
|
1.71%
|
$4.99
|
+3.71% (+276,248)
|
|||
|
2020 Q1
|
1.63%
|
$3.40
|
-11.51% (-968,723)
|
|||
|
2019 Q4
|
1.65%
|
$5.48
|
+0.03% (+2,700)
|
|||
|
2019 Q3
|
1.95%
|
$5.72
|
+4.54% (+365,350)
|
|||
|
2019 Q2
|
2.46%
|
$7.66
|
+13.61% (+964,175)
|
|||
|
2019 Q1
|
1.48%
|
$5.26
|
+45.24% (+2,206,810)
|
|||
|
2018 Q4
|
1.45%
|
$6.54
|
+3.64% (+171,125)
|
|||
|
2018 Q3
|
2.64%
|
$17.22
|
-1.27% (-60,575)
|
|||
|
2018 Q2
|
2.50%
|
$13.94
|
-0.89% (-42,875)
|
|||
|
2018 Q1
|
3.16%
|
$15.33
|
+4.93% (+225,825)
|
|||
|
2017 Q4
|
2.29%
|
$11.52
|
+24.84% (+912,175)
|
|||
|
2017 Q3
|
3.21%
|
$19.01
|
-1.21% (-45,000)
|
|||
|
2017 Q2
|
4.07%
|
$24.09
|
+6.58% (+229,575)
|
|||
|
2017 Q1
|
3.58%
|
$19.82
|
+13.25% (+408,100)
|
|||
|
2016 Q4
|
3.98%
|
$24.30
|
+0.14% (+4,400)
|
|||
|
2016 Q3
|
4.91%
|
$28.02
|
+0.10% (+2,950)
|
|||
|
2016 Q2
|
4.88%
|
$24.61
|
-8.20% (-274,250)
|
|||
|
2016 Q1
|
5.63%
|
$33.89
|
+5.60% (+177,375)
|
|||
|
2015 Q4
|
3.66%
|
$30.15
|
+7.63% (+224,700)
|
|||
|
2015 Q1
|
5.04%
|
$45.37
|
+0.09% (+2,600)
|
|||
|
2014 Q4
|
3.17%
|
$27.53
|
+1.86% (+53,800)
|
|||
|
2014 Q3
|
2.28%
|
$18.58
|
+3.09% (+86,425)
|
|||
|
2014 Q2
|
2.83%
|
$25.13
|
+69.66% (+1,150,200)
|
|||
|
2014 Q1
|
1.74%
|
$26.29
|
+40.76% (+478,125)
|
|||
|
2013 Q4
|
1.30%
|
$23.80
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.